Joseph Horton

456 total citations
24 papers, 370 citations indexed

About

Joseph Horton is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Joseph Horton has authored 24 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 8 papers in Infectious Diseases and 7 papers in Virology. Recurrent topics in Joseph Horton's work include HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (7 papers) and Biochemical and Molecular Research (4 papers). Joseph Horton is often cited by papers focused on HIV/AIDS drug development and treatment (8 papers), HIV Research and Treatment (7 papers) and Biochemical and Molecular Research (4 papers). Joseph Horton collaborates with scholars based in United States, United Kingdom and Japan. Joseph Horton's co-authors include Robert J. Pignolo, Vincent J. Cristofalo, Bart P. Keogh, Maria Tresini, Robert G. Allen, Minoru S.H. Ko, Glenn S. Gerhard, Bernard Martin, V. J. Cristofalo and Michael D. Hagen and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Joseph Horton

22 papers receiving 362 citations

Peers

Joseph Horton
Octavio A. Quiñones United States
Jeremy Mauldin United States
J. Navarro France
Bettina Cardel Switzerland
Guozhe Yang United States
Cynthia L. Courtney United States
Leah J. Anderson United States
K. Zimmer Germany
Joseph Horton
Citations per year, relative to Joseph Horton Joseph Horton (= 1×) peers Pichugin Av

Countries citing papers authored by Joseph Horton

Since Specialization
Citations

This map shows the geographic impact of Joseph Horton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Horton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Horton more than expected).

Fields of papers citing papers by Joseph Horton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joseph Horton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Horton. The network helps show where Joseph Horton may publish in the future.

Co-authorship network of co-authors of Joseph Horton

This figure shows the co-authorship network connecting the top 25 collaborators of Joseph Horton. A scholar is included among the top collaborators of Joseph Horton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph Horton. Joseph Horton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Underwood, Mark, José Castillo‐Mancilla, Lesley Kahl, et al.. (2025). Phase 1 Evaluation of VH4524184, a Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile. Clinical Infectious Diseases. 81(3). 510–520.
2.
Vavro, Cindy, Theodore Ruel, Andrew Wiznia, et al.. (2021). Emergence of Resistance in HIV-1 Integrase with Dolutegravir Treatment in a Pediatric Population from the IMPAACT P1093 Study. Antimicrobial Agents and Chemotherapy. 66(1). e0164521–e0164521. 21 indexed citations
3.
Pouliot, Jeffrey J., Michael M. Thomson, Joseph Horton, et al.. (2015). Preclinical Characterization and In Vivo Efficacy of GSK8853, a Small-Molecule Inhibitor of the Hepatitis C Virus NS4B Protein. Antimicrobial Agents and Chemotherapy. 59(10). 6539–6550. 6 indexed citations
4.
5.
Voitenleitner, Christian, Renae M. Crosby, Katja Remlinger, et al.. (2013). In Vitro Characterization of GSK2485852, a Novel Hepatitis C Virus Polymerase Inhibitor. Antimicrobial Agents and Chemotherapy. 57(11). 5216–5224. 10 indexed citations
6.
Wilfret, David, Kimberly K. Adkison, Yu Lou, et al.. (2013). Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GSK2336805, an Inhibitor of Hepatitis C Virus (HCV) NS5A, in Healthy Subjects and Subjects Chronically Infected with HCV Genotype 1. Antimicrobial Agents and Chemotherapy. 57(10). 5037–5044. 21 indexed citations
7.
Bechtel, Jill, Renae M. Crosby, Stephanie Van Horn, et al.. (2011). 764 IN VITRO PROFILING OF GSK2336805, A POTENT AND SELECTIVE INHIBITOR OF HCV NS5A. Journal of Hepatology. 54. S307–S308. 7 indexed citations
8.
D’Aquila, Richard T., Anna María Geretti, Joseph Horton, et al.. (2010). Tenofovir (TDF)-Selected or Abacavir (ABC)-Selected Low-Frequency HIV Type 1 Subpopulations During Failure with Persistent Viremia as Detected by Ultradeep Pyrosequencing. AIDS Research and Human Retroviruses. 27(2). 201–209. 15 indexed citations
9.
Ross, Lisa, Winkler G. Weinberg, Edwin DeJesus, et al.. (2010). Impact of Low Abundance HIV Variants on Response to Ritonavir-Boosted Atazanavir or Fosamprenavir Given Once Daily with Tenofovir/Emtricitabine in Antiretroviral-Naive HIV-Infected Patients. AIDS Research and Human Retroviruses. 26(4). 407–417. 8 indexed citations
10.
Ross, Lisa, Peter Gerondelis, E DeJesus, et al.. (2009). Low-abundance HIV species and their impact on mutational profiles in patients with virological failure on once-daily abacavir/lamivudine/zidovudine and tenofovir. Journal of Antimicrobial Chemotherapy. 65(2). 307–315. 6 indexed citations
11.
Pignolo, Robert J., Mitch O. Rotenberg, Joseph Horton, & Vincent J. Cristofalo. (1998). Senescent WI-38 Fibroblasts Overexpress LPC-1, a Putative Transmembrane Shock Protein. Experimental Cell Research. 240(2). 305–311. 5 indexed citations
12.
Ko, Minoru S.H., Joseph Horton, Josephine R. Paris, et al.. (1998). Genome-wide mapping of unselected transcripts from extraembryonic tissue of 7.5-day mouse embryos reveals enrichment in the t-complex and under-representation on the X chromosome. Human Molecular Genetics. 7(12). 1967–1978. 68 indexed citations
13.
Pignolo, Robert J., et al.. (1998). The Pathway of Cell Senescence: WI-38 Cells Arrest in Late G1 and Are Unable to Traverse the Cell Cycle from a True G0 State. Experimental Gerontology. 33(1-2). 67–80. 36 indexed citations
14.
Allen, Robert G., Bart P. Keogh, Maria Tresini, et al.. (1997). Development and Age-associated Differences in Electron Transport Potential and Consequences for Oxidant Generation. Journal of Biological Chemistry. 272(40). 24805–24812. 26 indexed citations
15.
Keogh, Bart P., Robert G. Allen, Robert J. Pignolo, et al.. (1996). Expression of hydrogen peroxide and glutathione metabolizing enzymes in human skin fibroblasts derived from donors of different ages. Journal of Cellular Physiology. 167(3). 512–522. 39 indexed citations
16.
Allen, Philip G., Bart P. Keogh, Glenn S. Gerhard, et al.. (1995). Expression and regulation of superoxide dismutase activity in human skin fibroblasts from donors of different ages. Journal of Cellular Physiology. 165(3). 576–587. 30 indexed citations
17.
Horton, Joseph, Michael D. Hagen, & Minoru S.H. Ko. (1994). Optimized conditions for cycle sequencing of PCR products.. Genome Research. 3(6). 359–360. 4 indexed citations
18.
Ko, Minoru S.H., et al.. (1994). Genetic mapping of 40 cDNA clones on the mouse genome by PCR. Mammalian Genome. 5(6). 349–355. 26 indexed citations
19.
Krebs, Christopher J., Joseph Horton, Chadwick Mullins, William Paradee, & R.T. Taggart. (1993). D11S971 CATT polymorphism (RC27) located near the MEN1 locus at 11q13. Human Molecular Genetics. 2(6). 825–825. 5 indexed citations
20.
Taggart, R.T., et al.. (1993). D11S970 CATT polymorphism (RC29) located near the MEN1 locus at 11q13. Human Molecular Genetics. 2(3). 336–336. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026